Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 2 · 100%High 0 · 0%

Indacaterol vs placebo

Serious adverse events · patients with chronic obstructive pulmonary disease

Indacaterol showed no clear difference in serious adverse events compared with placebo (moderate certainty).

1 finding from 1 review

Indacaterol, a once‐daily beta₂‐agonist, versus twice‐daily beta₂‐agonists or placebo for chronic obstructive… 2015 · Cochrane Headline outcomes only
OR 1 [0.82, 1.23]
9 studies · 6065 participants
Moderate

Indacaterol vs long‐acting beta2‐agonist alone

Serious adverse events Adverse events · patients with chronic obstructive pulmonary disease

Indacaterol showed no clear difference in serious adverse events Adverse events compared with twice‐daily long‐acting beta2‐agonists (moderate certainty).

1 finding from 1 review

Indacaterol, a once‐daily beta₂‐agonist, versus twice‐daily beta₂‐agonists or placebo for chronic obstructive… 2015 · Cochrane Headline outcomes only
OR 1.02 [0.79, 1.32]
4 studies · 3266 participants
Moderate